MTIP, a Swiss healthtech focused private equity firm, has closed its MTIP Fund II at USD250 million in capital commitments. 

The oversubscribed fund, which closed above its target of USD225 million, continues its predecessor fund’s strategy of investing in growing and innovative healthtech companies primarily across Europe.